Thomas Chen
Direktor/Vorstandsmitglied bei Cognos Therapeutics, Inc.
Profil
Thomas Chen is currently working as the Director, Chief Neuro-Surgeon & Oncology Officer at Cognos Therapeutics, Inc. and Cognos Therapeutics Holdings, Inc. He completed his undergraduate degree in 1995 and doctorate in 1996 from the University of Southern California.
He also completed his doctorate from The University of California, San Francisco in 1988 and his undergraduate degree from the University of Illinois.
Aktive Positionen von Thomas Chen
| Unternehmen | Position | Beginn |
|---|---|---|
Cognos Therapeutics, Inc.
 Cognos Therapeutics, Inc. BiotechnologyHealth Technology Cognos Therapeutics, Inc. operates as a medical device company focusing on creating technologies to diagnosis and treatment of neuropathic diseases. Its treatment of diseases including tumor-based brain and spinal cancers, degenerative cognition disorders (such as Alzheimer?s and Parkinson?s disease), cerebral trauma occurrences (such as epilepsy and stroke) as well as other central nervous system afflictions. The company is headquartered in Los Angeles, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Thomas Chen
| The University of California, San Francisco | Doctorate Degree |
| University of Southern California | Undergraduate Degree |
| University of Illinois | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Cognos Therapeutics, Inc.
Cognos Therapeutics, Inc. BiotechnologyHealth Technology Cognos Therapeutics, Inc. operates as a medical device company focusing on creating technologies to diagnosis and treatment of neuropathic diseases. Its treatment of diseases including tumor-based brain and spinal cancers, degenerative cognition disorders (such as Alzheimer?s and Parkinson?s disease), cerebral trauma occurrences (such as epilepsy and stroke) as well as other central nervous system afflictions. The company is headquartered in Los Angeles, CA. | Health Technology |
